Gordon Neal, President, New Pacific Metals explains why silver outperforms gold in a bull market #NUAG #Silver #Mining Watch Now

Less Ads, More Data, More Tools Register for FREE
Gordon Neal, President, New Pacific Metals explains why silver outperforms gold in a bull market #NUAG #Silver #Mining
Gordon Neal, President, New Pacific Metals explains why silver outperforms gold in a bull market #NUAG #Silver #MiningView Video
Paul Mylchreest, Hardman & Co Mining Analyst puts the gold market in context #Hardman #Gold #Silver
Paul Mylchreest, Hardman & Co Mining Analyst puts the gold market in context #Hardman #Gold #SilverView Video

Pin to quick picksAdvanced Oncotherapy Share Price (AVO)

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.50
Bid: 29.00
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 3.00 (10.34%)
Open: 30.50
High: 30.50
Low: 30.50
Yest. Close: 30.50
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Advanced Oncotherapy Plc Ord 25P

Advanced Oncotherapy is listed in the FTSE AIM All-Share index.

Advanced Oncotherapy is part of the Health Care and Related Services sector.

Advanced Oncotherapy Plc Ord 25P is listed on the London Stock Exchange, trading with ticker code AVO. It has a market capitalisation of £102m, with approximately 333m shares in issue. Over the last year, Advanced Oncotherapy share price has been traded in a range of 22.5, hitting a high of 43, and a low of 20.5.
Advanced Oncotherapy Share Price
Price 30.50
Bid 29.00
Ask 32.00
Change 0.00 (0.00%)
Volume 36,119
Open 30.50
High 30.50
Low 30.50
Close 30.50
Currency GBX
Currency GBX
Issue Country GB
Shares in Issue 333m
Market Capitalisation £102m
Market Size 4,000
52 Week High 43.00
52 Week High Date 30-Dec-2019
52 Week Low 20.50
52 Week Low Date 16-Mar-2020
# Trades 9
Vol. Sold 6,700
Sold Value £2,044
Vol. Bought 4,419
Bought Value £1,348
PE Ratio -3.103
Earnings -9.83
Dividend 0.00
Yield 0.00%

Recent Share Trades for Advanced Oncotherapy (AVO)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
26-Nov-2008:12:1732.0093,709Buy*29.0032.0029.99kO Ordinary
Delayed publication
Historical
27-Nov-2016:29:5630.275571Sell*29.0032.00172.87O Ordinary
27-Nov-2016:25:5231.3991,086Buy*29.0032.00340.99O Ordinary
27-Nov-2016:23:5131.3992,500Buy*29.0032.00784.98O Ordinary
27-Nov-2010:24:2030.25525,000Sell*29.0032.007,564O Ordinary
Delayed publication
27-Nov-2011:13:4329.8751,129Sell*29.0032.00337.29O Ordinary
27-Nov-2009:05:1531.40235Buy*29.0032.0073.79O Ordinary
27-Nov-2008:05:3530.2552,829Sell*29.0032.00855.91O Ordinary
27-Nov-2008:03:3631.40598Buy*29.0032.00187.77O Ordinary
27-Nov-2008:01:0430.2552,171Sell*29.0032.00656.84O Ordinary

Directors Deals for Advanced Oncotherapy (AVO)

Announced Traded Action Notifier Price Currency Amount Holding
26-Oct-2026-Oct-20Placing Hans von Celsing held the position of Non-Executive Director at the time of this trade. Hans von Celsing30.00GBX250,000512,500
26-Oct-2026-Oct-20Placing Nick Plowman held the position of Non-Executive Director at the time of this trade. Nick Plowman30.00GBX250,0004,662,804
26-Oct-2026-Oct-20Placing Enrico Cipro Vanni held the position of Non-Executive Director at the time of this trade. Enrico Cipro Vanni30.00GBX250,0002,546,361
26-Oct-2026-Oct-20Placing Michael Bradfield held the position of Non-Executive Director at the time of this trade. Michael Bradfield30.00GBX250,0007,443,240
18-Aug-2018-Aug-20Buy Michael J Sinclair held the position of Executive Chairman at the time of this trade. Michael J Sinclair3,397.00GBX80,0008,280,604
  • You must have an account to view chat. Click here to register

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.